Skip to main content
Clinical Trials/RBR-3m5rqzh
RBR-3m5rqzhNot yet recruitingUnknown

Repetitive Transcranial Magnetic Stimulation in the adjunctive treatment of Neurodegenerative Disorders

Instituto de Psiquiatria da Universidade Federal do Rio de Janeiro0 sitesStarted: August 28, 2023Last updated:

Trial Snapshot

Phase
Unknown
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
50Y to 0 (—)

Inclusion Criteria

  • Diagnosis of dementia,Complementary imaging exam for the diagnosis of dementia;either Alzheimer's Dementia, Mixed,Frontotemporal Lobar Degeneration,Lewy bodies, among others;use of acetylcholinesterase inhibitors and or memantine in doses stable for at least 3 months;clinical dementia rating = 2;the patient must be able to communicate,read and understand the term informed consent and be able to carry out assessments neuropsychological

Exclusion Criteria

  • Comorbidity with previously diagnosed psychiatric illness,contraindications to performing the neuromodulation method non-invasive like epilepsy,metal brain implants, non-removable metallic implants, cardioverter defibrillators,implantable devices, trauma or brain tumor;decompensated clinical disease like neoplasms, heart disease, pulmonary, hepatic, renal,and endocrine

Investigators

Sponsor
Instituto de Psiquiatria da Universidade Federal do Rio de Janeiro

Similar Trials